TY - JOUR
T1 - New evidence for the role of TNF-α in liver ischaemic/reperfusion injury
AU - Pevni, D.
AU - Frolkis, I.
AU - Schwartz, D.
AU - Schwartz, I.
AU - Chernichovski, T.
AU - Kramer, A.
AU - Ben-Gal, Y.
AU - Uretzky, G.
AU - Shapira, I.
AU - Weinbroum, A.
PY - 2008/9
Y1 - 2008/9
N2 - Background: Tumour necrosis factor-alpha (TNF-α) plays a key role in causing ischaemia/reperfusion (I/R) injury. I/R also causes activation of xanthine oxidase and dehydrogenase (XDH + XO) system that, via generated free radicals, causes organ damage. We investigated the effect of ischaemia, reperfusion and non-ischaemic prolonged perfusion (NIP) on TNF-α and XDH + XO production in an isolated perfused rat liver model. Materials and methods: Rat livers underwent 150 min NIP (control group) or two hours of ischaemia followed by reperfusion (I/R group). TNF-α (TNF-α mRNA and protein level), XDH + XO production and bile secretion were determined in tissue and effluent at baseline, at 120 min of ischaemia, after 30 min of reperfusion (I/R group) and after 120 and 150 min of prolonged perfusion (control). Results: Unexpectedly, neither ischaemia nor reperfusion had any effect on TNF-α production. TNF-α in effluent was 11 ± 4.8 pg mL-1 at baseline, 7 ± 3.2 pg mL-1 at the end of ischaemia, and 13 ± 5.3 pg mL-1 after 30 min of reperfusion. NIP, however, caused a significant increase of TNF-α synthesis and release. TNF-α effluent level after 120 and 150 min of perfusion was 392 ± 78.7 pg mL-1 and 408 ± 64.3 pg mL-1, respectively. TNF-α mRNA in tissue was also significantly elevated compared to baseline levels (1.31 ± 0.2 P < 0.001 and 1.38 P < 0.002, respectively). Decrease of liver function (expressed by bile secretion) during I/R and NIP was accompanied by significant XDH + XO elevation. Conclusion: This is the first evidence that NIP, and not I/R, is the decisive trigger for TNF-α production. This study leads to a better understanding of pathogenesis of liver I/R and perfusion damage.
AB - Background: Tumour necrosis factor-alpha (TNF-α) plays a key role in causing ischaemia/reperfusion (I/R) injury. I/R also causes activation of xanthine oxidase and dehydrogenase (XDH + XO) system that, via generated free radicals, causes organ damage. We investigated the effect of ischaemia, reperfusion and non-ischaemic prolonged perfusion (NIP) on TNF-α and XDH + XO production in an isolated perfused rat liver model. Materials and methods: Rat livers underwent 150 min NIP (control group) or two hours of ischaemia followed by reperfusion (I/R group). TNF-α (TNF-α mRNA and protein level), XDH + XO production and bile secretion were determined in tissue and effluent at baseline, at 120 min of ischaemia, after 30 min of reperfusion (I/R group) and after 120 and 150 min of prolonged perfusion (control). Results: Unexpectedly, neither ischaemia nor reperfusion had any effect on TNF-α production. TNF-α in effluent was 11 ± 4.8 pg mL-1 at baseline, 7 ± 3.2 pg mL-1 at the end of ischaemia, and 13 ± 5.3 pg mL-1 after 30 min of reperfusion. NIP, however, caused a significant increase of TNF-α synthesis and release. TNF-α effluent level after 120 and 150 min of perfusion was 392 ± 78.7 pg mL-1 and 408 ± 64.3 pg mL-1, respectively. TNF-α mRNA in tissue was also significantly elevated compared to baseline levels (1.31 ± 0.2 P < 0.001 and 1.38 P < 0.002, respectively). Decrease of liver function (expressed by bile secretion) during I/R and NIP was accompanied by significant XDH + XO elevation. Conclusion: This is the first evidence that NIP, and not I/R, is the decisive trigger for TNF-α production. This study leads to a better understanding of pathogenesis of liver I/R and perfusion damage.
KW - Injury
KW - Isolated perfused liver
KW - TNF
UR - http://www.scopus.com/inward/record.url?scp=49749091635&partnerID=8YFLogxK
U2 - 10.1111/j.1365-2362.2008.01996.x
DO - 10.1111/j.1365-2362.2008.01996.x
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 18837741
AN - SCOPUS:49749091635
SN - 0014-2972
VL - 38
SP - 649
EP - 655
JO - European Journal of Clinical Investigation
JF - European Journal of Clinical Investigation
IS - 9
ER -